Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.
Tyla Last week Weeks at no. 1 Weeks on chart Gains In Performance Week of February 1, 2025 click to see more Gains In Performance Gains In Performance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback